R&D Systems™ Recombinant Human Amyloid Precursor Protein Fc Chimera

Catalog No.	Quantity
99-37A-P100	100 μg

Catalog No. 99-37A-P100 Supplier R&D Systems™ Supplier No. 9937AP100

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Amyloid Precursor Protein Fc Chimera is derived from NS0. The Recombinant Human Amyloid Precursor Protein Fc Chimera has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P05067-4
• For Use With (Application): Bioactivity
• Molecular Weight (g/mol): 94 kDa
• Quantity: 100 μg
• Source: Mouse myeloma cell line,NS0-derived human APP695 protein, (N-terminus) Human Amyloid-beta A4 (Isoform APP695) (Leu18-Lys612) Accession &Num; P05067-4 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Specific Reactivity: APP695
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Purity or Quality Grade: >85%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie« Blue Staining.